IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Anlon Healthcare Ltd.
Issue Open Date 26-Aug-25  
Issue Closing Date 29-Aug-25  
Application Money 100  
Allotment Money  
Price Band 86 - 91  
Minimium Application No. 164  
Issue Size (Shares) 13300000  
Market Lot 1.00  
Objective
1. Funding capital expenditure requirements for expansion of our Manufacturing Facility (“Proposed Expansion”);2. Full or part repayment and/or prepayment of certain outstanding secured borrowings (term loan) availed by our Company;3. Funding the working capital requirements of our Company; and4. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1995000   21161412   10.61  
Qualified Institutional Buyers   9975000   10689028   1.07  
Retail Individual Investors   1330000   62912368   47.30  
Business Description
We are a R&D driven chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates (“Pharma Intermediate”) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingre
more...
Promoter's Holding
Total Share Capital   28000000  
Offered to Public   13300000  
Promoter's Holding (Pre-Issue)   70.26  
Promoter's Holding (Post-Issue)   52.68  
Address
101/102
Silvercoin Complex
Opp. Crystal Mall
Kalawad Road
Rajkot ,
Gujarat ,
360005
Phone: 0281 2562538/39
Email: cs@anloncro.com
Website: www.anlon.in
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Interactive Financial Services Ltd.
Promoters
Mamata Punitkumar Rasadia
Meet Atulkumar Vachhani
Punitkumar R. Rasadia
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.